Hear from our CEO, Adrian Treverton, about treating non-melanoma skin cancer patients safely during COVID. Patients most likely to develop basal or squamous cell carcinoma are those in the age range at greater risk of serious illness from COVID, so safe and short...
One common question dermatologists often ask about incorporating radiation therapy into their practice is “How much involvement do I need from a radiation oncologist?” Regulations concerning physician supervision, reimbursement, and radiation shielding can vary quite...
In the published study, "Split Course Superficial Radiotherapy in Scrotal Extramammary Paget’s Disease Allows Course Completion With Minimal Side Effects: A Case Study" by Gerald B. Fogarty, et al., the Xstrahl 300 system was used to treat Paget's disease to a...
Hear from Xstrahl's CEO, Adrian Treverton, on the future of skin cancer treatment. https://vimeo.com/718012693
Kilovoltage X-ray equipment maintains an integral role in the modern radiation therapy department for the treatment of non-melanoma skin cancer as well as other benign conditions and palliative applications. The use of low energy, therapeutic X-rays is often a...
George Wilson, PhD, Chief, Radiation Biology, William Beaumont Hospital Radiation Biology focuses on translational research in the areas of new treatments, combined modalities, and stem cell biology. The group has a heavy emphasis on incorporating molecular,...
Skin cancer is an increasingly common condition, particularly keratinocytic cancers like basal cell carcinoma and cutaneous squamous cell carcinoma. Surgery has been the standard treatment for these, but affects functional and/or cosmetic outcomes. Definitive...
SmART-XPS is one of the Treatment Planning System options for our Small Animal Radiation Research Platform (SARRP), alongside MuriPlan. Both systems have a wide range of features and capabilities. Learn more about SmART-XPS below.
Non-melanoma skin cancer is the most common cancer in the world today, with approximately 1.5 million cases in 2016—and that number is growing rapidly. While this type of cancer has a low morbidity rate, surgical treatment often leaves patients with dysfunctions,...
Contact Us